Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
+$208M |
| 2 |
Norfolk Southern
NSC
|
+$145M |
| 3 |
Insmed
INSM
|
+$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$136M |
| 5 |
Soleno Therapeutics
SLNO
|
+$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$355M |
| 2 |
Royalty Pharma
RPRX
|
+$334M |
| 3 |
McDonald's
MCD
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$188M |
| 5 |
HES
Hess
HES
|
+$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
VICI Properties
VICI
$35.3B
| $39.5M | 0.07% |
1,212,100
-512,300
| -30% | -$16.7M |
|
|
ITCI
277
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $39.4M | 0.07% |
298,391
-379,609
| -56% | -$50.1M |
|
278
Fair Isaac
FICO
$37.1B
| $39.3M | 0.07% |
21,300
-1,500
| -7% | -$2.77M |
|
279
Centene
CNC
$15.3B
| $39.2M | 0.07% |
646,228
+174,516
| +37% | +$10.6M |
|
280
Henry Schein
HSIC
$8.2B
| $39.2M | 0.07% |
572,455
+82,142
| +17% | +$5.63M |
|
281
Travere Therapeutics
TVTX
$1.93B
| $39.2M | 0.07% |
2,184,898
+1,808,098
| +480% | +$32.4M |
|
282
Warrior Met Coal
HCC
$3.06B
| $39.1M | 0.07% |
820,000
+660,000
| +413% | +$31.5M |
|
283
Amcor
AMCR
$18.9B
| $39M | 0.07% |
4,019,090
+2,207,746
| +122% | +$21.4M |
|
284
Roivant Sciences
ROIV
$9.21B
| $38.5M | 0.07% |
3,819,983
-1,900,000
| -33% | -$19.2M |
|
285
Vistra
VST
$65.7B
| $38.5M | 0.07% |
328,000
-129,900
| -28% | -$15.3M |
|
286
Autodesk
ADSK
$69.3B
| $38.3M | 0.07% |
146,189
-34,700
| -19% | -$9.08M |
|
287
MeiraGTx Holdings
MGTX
$615M
| $38.2M | 0.07% |
5,634,578
+600,000
| +12% | +$4.07M |
|
288
Ocular Therapeutix
OCUL
$2.22B
| $38.1M | 0.07% |
5,200,000
+1,600,000
| +44% | +$11.7M |
|
289
CNX Resources
CNX
$4.12B
| $37.8M | 0.07% |
1,200,000
+1,004,545
| +514% | +$31.6M |
|
290
Allstate
ALL
$52.7B
| $37.6M | 0.07% |
181,819
-115,600
| -39% | -$23.9M |
|
291
Monster Beverage
MNST
$61.9B
| $37.4M | 0.07% |
639,022
-15,200
| -2% | -$890K |
|
292
AvalonBay Communities
AVB
$27.8B
| $36.4M | 0.07% |
169,738
-17,720
| -9% | -$3.8M |
|
293
Ametek
AME
$43.3B
| $36.3M | 0.07% |
211,141
+47,000
| +29% | +$8.09M |
|
294
Corpay
CPAY
$22.1B
| $36.1M | 0.07% |
103,658
+26,000
| +33% | +$9.07M |
|
295
Guardant Health
GH
$7.41B
| $36.1M | 0.07% |
846,749
+566,949
| +203% | +$24.2M |
|
296
Edison International
EIX
$21.1B
| $35.5M | 0.07% |
603,304
+241,600
| +67% | +$14.2M |
|
297
Zebra Technologies
ZBRA
$15.9B
| $35.3M | 0.07% |
124,911
+41,700
| +50% | +$11.8M |
|
298
News Corp Class A
NWSA
$16.6B
| $35.2M | 0.07% |
1,294,599
+233,820
| +22% | +$6.36M |
|
299
Axon Enterprise
AXON
$57.5B
| $34.8M | 0.06% |
66,100
-1,600
| -2% | -$842K |
|
300
MSCI
MSCI
$44B
| $34.3M | 0.06% |
60,600
-8,900
| -13% | -$5.03M |
|